Advertisement
Home 2017 March

Monthly Archives: March 2017

Effective treatment of benzodiazepine dependence includes cognitive behavioral therapy and motivational approaches

Review: Treatment Options for Benzodiazepine Dependence

0
Good evidence for cognitive behavioral therapy and motivational approaches to dependence
Prophylactic use of the subcutaneous C1 inhibitor CSL830 is associated with a reduction in the frequency of acute attacks in patients with hereditary angioedema

C1 Inhibitor Use Reduces Attacks in Hereditary Angioedema

0
Subcutaneous CSL830 at doses of 40 and 60 IU reduce rate of attacks, need for rescue medication
For patients with sepsis requiring mechanical ventilation

DEX Doesn’t Reduce Mortality in Those With Sepsis on Ventilator

0
Dexmedetomidine also did not reduce ventilator-free days for sepsis patients on mechanical ventilation
For Medicare beneficiaries after myocardial infarction (MI) hospitalization

Statin Intolerance Tied to Increased Risk of Recurrent MI

0
Higher rate of recurrent MI, coronary heart disease for Medicare beneficiaries post-MI hospitalization
For obese or overweight individuals without type 2 diabetes

CANA/PHEN Aids Weight Loss in Obese Without Type 2 Diabetes

0
Canagliflozin plus phentermine superior to placebo for weight loss at 26 weeks in obese, overweight
Xadago (safinamide) tablets have been approved by the U.S. Food and Drug Administration as an add-on drug to treat Parkinson's patients who take levodopa or carbidopa but experience "off" episodes.

FDA Approves New Parkinson’s Add-On Drug Xadago

0
To help prevent 'off' episodes among users of levodopa/carbidopa
From 2005 to 2014

Infant Mortality Down in United States From 2005 to 2014

0
Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women
For patients with hypoxemia after cardiac surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

0
Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx
Pregabalin does not significantly reduce the intensity of leg pain associated with sciatica

Pregabalin Doesn’t Cut Intensity of Sciatica-Linked Leg Pain

0
No significant difference in leg-pain intensity score at week eight or 52 for pregabalin, placebo
Direct-to-consumer telehealth may increase health care utilization and spending

Telehealth Ups Access, Spending for Acute Respiratory Illness

0
Eighty-eight percent of telehealth visits for ARI were new utilization; increase in net spending per user